Vanda Pharmaceuticals Inc. (LON:0LKB)

Vanda Pharmaceuticals Statistics

Total Valuation

LON:0LKB has a market cap or net worth of GBP 197.49 million. The enterprise value is -17.33 million.

Market Cap	197.49M
Enterprise Value	-17.33M

Important Dates

The last earnings date was Wednesday, October 29, 2025.

Earnings Date	Oct 29, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	59.10M
Shares Outstanding	n/a
Shares Change (YoY)	+1.34%
Shares Change (QoQ)	+0.17%
Owned by Insiders (%)	5.14%
Owned by Institutions (%)	65.75%
Float	49.49M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.25
PB Ratio	0.57
P/TBV Ratio	0.74
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	0.28
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	0.28

Financial Position

The company has a current ratio of 3.12, with a Debt / Equity ratio of 0.02.

Current Ratio	3.12
Quick Ratio	2.92
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	-0.13
Interest Coverage	-31.98

Financial Efficiency

Return on equity (ROE) is -16.72% and return on invested capital (ROIC) is -14.75%.

Return on Equity (ROE)	-16.72%
Return on Assets (ROA)	-12.15%
Return on Invested Capital (ROIC)	-14.75%
Return on Capital Employed (ROCE)	-25.06%
Revenue Per Employee	428,724
Profits Per Employee	-170,215
Employee Count	368
Asset Turnover	0.34
Inventory Turnover	6.46

Taxes

Income Tax	-17.07M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -8.53% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-8.53%
50-Day Moving Average	4.91
200-Day Moving Average	4.63
Relative Strength Index (RSI)	30.43
Average Volume (20 Days)	3,585

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	7.09

Income Statement

In the last 12 months, LON:0LKB had revenue of GBP 157.77 million and -62.64 million in losses. Loss per share was -1.07.

Revenue	157.77M
Gross Profit	148.99M
Operating Income	-90.09M
Pretax Income	-79.71M
Net Income	-62.64M
EBITDA	-84.12M
EBIT	-90.09M
Loss Per Share	-1.07

Balance Sheet

The company has 218.53 million in cash and 8.12 million in debt, giving a net cash position of 210.41 million.

Cash & Cash Equivalents	218.53M
Total Debt	8.12M
Net Cash	210.41M
Net Cash Per Share	n/a
Equity (Book Value)	346.68M
Book Value Per Share	5.87
Working Capital	185.71M

Cash Flow

In the last 12 months, operating cash flow was -60.89 million and capital expenditures -825,773, giving a free cash flow of -61.71 million.

Operating Cash Flow	-60.89M
Capital Expenditures	-825,773
Free Cash Flow	-61.71M
FCF Per Share	n/a

Margins

Gross margin is 94.44%, with operating and profit margins of -57.10% and -39.70%.

Gross Margin	94.44%
Operating Margin	-57.10%
Pretax Margin	-50.52%
Profit Margin	-39.70%
EBITDA Margin	-53.31%
EBIT Margin	-57.10%
FCF Margin	n/a

Dividends & Yields

LON:0LKB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.34%
Shareholder Yield	-1.34%
Earnings Yield	-31.72%
FCF Yield	-31.25%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0LKB has an Altman Z-Score of 0.8 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.8
Piotroski F-Score	3